Vicarious Surgical (RBOT) Gains from Sales and Divestitures (2021 - 2023)
Vicarious Surgical (RBOT) reported Gains from Sales and Divestitures of $279656.0 for Q2 2023, up 169.55% year-over-year from $103749.0 in Q2 2022, and up 1.71% quarter-over-quarter from $274951.0 in Q1 2023.
Vicarious Surgical (RBOT) Gains from Sales and Divestitures (2021 - 2023) Analysis & Trends
Vicarious Surgical (RBOT) has 3 years of Gains from Sales and Divestitures data on file, last reported at $279656.0 in Q2 2023.
- Gains from Sales and Divestitures for Q2 2023 came in at $279656.0, up 169.55% year-over-year; the trailing twelve-month figure through Jun 2023 was $279656.0 (up 169.55% YoY), and the FY2022 annual result was $769269.0, changed 0.0% from the prior year.
- Gains from Sales and Divestitures improved to $279656.0 in Q2 2023 per RBOT's latest filing, from $274951.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $769269.0 in Q4 2021 and troughed at $56716.0 in Q1 2022.
- A 3-year average of $365420.7 and a median of $279656.0 in 2023 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2023: Gains from Sales and Divestitures changed 0.0% in 2022, then jumped 384.79% in 2023.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $769269.0 in 2021, then changed by 0.0% to $769269.0 in 2022, then tumbled by 63.65% to $279656.0 in 2023.
- Business Quant data shows RBOT's Gains from Sales and Divestitures at $279656.0 in Q2 2023, $274951.0 in Q1 2023, and $769269.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 279,656.00 |
| Jun 30, 2023 | 279,656.00 |
| Mar 31, 2023 | 274,951.00 |
| Mar 31, 2023 | 274,951.00 |
| Dec 31, 2022 | 769,269.00 |
| Dec 31, 2022 | 769,269.00 |
| Sep 30, 2022 | 304,335.00 |
| Sep 30, 2022 | 304,335.00 |
| Jun 30, 2022 | 103,749.00 |
| Jun 30, 2022 | 103,749.00 |
| Mar 31, 2022 | 56,716.00 |
| Mar 31, 2022 | 56,716.00 |
| Dec 31, 2021 | 769,269.00 |
| Dec 31, 2021 | 769,269.00 |